Los Angeles, CA, United States of America

Xiaohong Chen

This inventor holds 1 USPTO granted patent and 3 published patent applications. Top assignee: University of California. Active years: 2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Xiaohong Chen. Retrieved from https://idiyas.com/inventor/xiaohong-chen-7enqp98y

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 1 

% Patents Active = 100.0

Average Co-Inventor Count = 5.0

ph-index = 1


Company Filing History:


Years Active: 2025

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Innovations of Xiaohong Chen in Cancer Research

Introduction

Xiaohong Chen is a prominent inventor based in Los Angeles, CA. She has made significant contributions to the field of cancer research, particularly in the modulation of the Wnt/beta-catenin pathway. Her work is crucial in developing new therapeutic strategies for colorectal cancer and other related conditions.

Latest Patents

Xiaohong Chen holds 1 patent titled "Inhibitors of the Wnt/beta-catenin pathway." This patent relates to compounds that can modulate the WNT/Beta-Catenin pathway, which is vital for understanding and treating various cancers. The methods disclosed in her patent aim to provide new avenues for treating colorectal cancer and other WNT/Beta-Catenin mediated cancers.

Career Highlights

Xiaohong Chen is affiliated with the University of California, where she conducts her research. Her academic background and ongoing research projects have positioned her as a key figure in the field of cancer therapeutics.

Collaborations

Xiaohong collaborates with notable colleagues, including Jie Zheng and Michael E Jung. Their combined expertise enhances the research efforts in cancer treatment and drug development.

Conclusion

Xiaohong Chen's innovative work in cancer research exemplifies the impact of scientific inquiry on medical advancements. Her contributions to understanding the Wnt/beta-catenin pathway are paving the way for new treatment options for patients.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…